Biosig Technologies Return on Equity

Biosig Technologies (BSGM) currently reports a ROE of -318.68%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore Biosig Technologies's ROE history and peer comparisons.

Biosig Technologies's ROE of -318.68% is lower than the Healthcare sector average of 29.33%. That is roughly 1186.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Biosig Technologies's current -318.68% should be judged against Healthcare norms (sector average: 29.33%) and against BSGM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -318.68%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Biosig Technologies, and consider following BSGM for alerts when major investors trade the stock.

Biosig Technologies is classified in the Healthcare sector. On ROE, it currently shows -318.68% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BSGM with unrelated industries.